-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
US vaccine panel upends hepatitis B advice in latest Trump-era shift
An advisory panel appointed by the Trump administration's vaccine-skeptic health secretary voted Friday to stop recommending that all newborns in the United States receive a hepatitis B vaccine.
The move to end the decades-old recommendation is the panel's latest contentious about-face on vaccine policy since its overhaul by Health Secretary Robert F. Kennedy Jr. earlier this year.
US health authorities previously recommended all babies, not just those born to mothers believed to have hepatitis B, receive the first of three vaccine doses just after birth.
The approach aimed, in part, to prevent transfers from mothers who unknowingly had hepatitis B or had falsely tested negative, and had virtually eradicated infections of the potentially deadly liver disease among young people in the country.
After delaying the vote by a day, the panel on Friday passed its new recommendation for "individual-based decision-making," in consultation with a health care provider, when children are born to mothers testing negatively for the disease.
The decision to vaccinate at birth should "consider vaccine benefits, vaccine risks, and infection risks."
The new recommendation was immediately condemned by several medical groups who noted widespread shortcomings in US maternal health screening as well as the possibility of infections from others.
"This irresponsible and purposely misleading guidance will lead to more hepatitis B infections in infants and children," American Academy of Pediatrics President Susan J. Kressly said in a statement.
The vote was 8-3. Trump-appointed officials at the Centers for Disease Control and Prevention (CDC) are expected to formally adopt the recommendations at a later date.
The panel also voted to recommend that babies who are not vaccinated at birth wait at least two months to get the initial dose, and that blood tests be done to measure antibodies before a second dose.
- Panel overhaul -
After becoming health secretary, Kennedy sacked every member of the once-staid Advisory Committee on Immunization Practices (ACIP), replacing them with figures whose vaccine-skeptic views track more closely with his own.
It has since set to work on reviewing prior recommendations -- already tweaking advice on Covid-19 and measles shots.
Medical experts fear the push could further contribute to declining vaccination rates in the United States.
The panel on Friday also began a broader review of the childhood vaccination schedule, and sparked further controversy by allowing testimony from lawyer Aaron Siri, a close Kennedy associate known for spreading unfounded theories on the subject.
While US President Donald Trump vocally supports Kennedy's policies, some in the Republican Party have pushed back, notably Louisiana Senator Bill Cassidy.
Medical doctor Cassidy condemned the ACIP decision on Friday, noting the original recommendation was never "a mandate" to get the jab.
CDC officials "should not sign these new recommendations and instead retain the current, evidence-based approach," he said on X.
Cassidy's expression of alarm, like his prior statements against Kennedy, provoked criticism after he provided the key vote to confirm the health secretary in February.
- 'Do no harm' -
The United States had urged universal vaccination at birth against hepatitis B since 1991, advice also recommended by China, Australia and the World Health Organization.
But several ACIP members argued Friday's decision would align the United States with other economically developed countries such as France and Britain.
The repercussions of the ACIP's vaccine recommendations are broad because federal guidelines often dictate whether vaccines are paid for by health insurance companies in the United States, where a vaccine can cost hundreds of dollars.
But the committee's influence is waning amid withering criticism from the US scientific and medical community, with Democratic-led states announcing they will no longer follow its recommendations.
Ahead of the vote, Dr. Cody Meissner, one of the few dissenting voices on the advisory committee, urged his colleagues not to change the current recommendations.
"Do no harm is a moral imperative. We are doing harm by changing this wording," he warned.
P.Smith--AT